Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002007377 | SCV002234431 | pathogenic | not provided | 2022-12-23 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr135*) in the MPV17 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MPV17 are known to be pathogenic (PMID: 23714749). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1451738). This variant has not been reported in the literature in individuals affected with MPV17-related conditions. This variant is not present in population databases (gnomAD no frequency). |
Baylor Genetics | RCV003471121 | SCV004193765 | likely pathogenic | Charcot-Marie-Tooth disease, axonal, type 2EE | 2022-12-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005025513 | SCV005655950 | likely pathogenic | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type); Charcot-Marie-Tooth disease, axonal, type 2EE | 2024-05-31 | criteria provided, single submitter | clinical testing |